135 related articles for article (PubMed ID: 34907647)
1. Mining the bacterial genome to discover new antimicrobial molecules.
Liang W; Diana J
EMBO Mol Med; 2022 Feb; 14(2):e15409. PubMed ID: 34907647
[TBL] [Abstract][Full Text] [Related]
2. Integrated evolutionary analysis reveals antimicrobial peptides with limited resistance.
Spohn R; Daruka L; Lázár V; Martins A; Vidovics F; Grézal G; Méhi O; Kintses B; Számel M; Jangir PK; Csörgő B; Györkei Á; Bódi Z; Faragó A; Bodai L; Földesi I; Kata D; Maróti G; Pap B; Wirth R; Papp B; Pál C
Nat Commun; 2019 Oct; 10(1):4538. PubMed ID: 31586049
[TBL] [Abstract][Full Text] [Related]
3. Synergistic activity profile of an antimicrobial peptide against multidrug-resistant and extensively drug-resistant strains of Gram-negative bacterial pathogens.
Pollini S; Brunetti J; Sennati S; Rossolini GM; Bracci L; Pini A; Falciani C
J Pept Sci; 2017 Apr; 23(4):329-333. PubMed ID: 28176481
[TBL] [Abstract][Full Text] [Related]
4. Romo1-Derived Antimicrobial Peptide Is a New Antimicrobial Agent against Multidrug-Resistant Bacteria in a Murine Model of Sepsis.
Lee HR; You DG; Kim HK; Sohn JW; Kim MJ; Park JK; Lee GY; Yoo YD
mBio; 2020 Apr; 11(2):. PubMed ID: 32291307
[TBL] [Abstract][Full Text] [Related]
5. Aedesin: structure and antimicrobial activity against multidrug resistant bacterial strains.
Godreuil S; Leban N; Padilla A; Hamel R; Luplertlop N; Chauffour A; Vittecoq M; Hoh F; Thomas F; Sougakoff W; Lionne C; Yssel H; Missé D
PLoS One; 2014; 9(8):e105441. PubMed ID: 25162372
[TBL] [Abstract][Full Text] [Related]
6. Adaptively evolved human oral actinomyces-sourced defensins show therapeutic potential.
Zhu S; Gao B; Umetsu Y; Peigneur S; Li P; Ohki S; Tytgat J
EMBO Mol Med; 2022 Feb; 14(2):e14499. PubMed ID: 34927385
[TBL] [Abstract][Full Text] [Related]
7. Degradable antimicrobial polycarbonates with unexpected activity and selectivity for treating multidrug-resistant Klebsiella pneumoniae lung infection in mice.
Yang C; Lou W; Zhong G; Lee A; Leong J; Chin W; Ding B; Bao C; Tan JPK; Pu Q; Gao S; Xu L; Hsu LY; Wu M; Hedrick JL; Fan W; Yang YY
Acta Biomater; 2019 Aug; 94():268-280. PubMed ID: 31129359
[TBL] [Abstract][Full Text] [Related]
8. Development of novel ultrashort antimicrobial peptide nanoparticles with potent antimicrobial and antibiofilm activities against multidrug-resistant bacteria.
Almaaytah A; Mohammed GK; Abualhaijaa A; Al-Balas Q
Drug Des Devel Ther; 2017; 11():3159-3170. PubMed ID: 29138537
[TBL] [Abstract][Full Text] [Related]
9. A novel smaller β-defensin-derived peptide is active against multidrug-resistant bacterial strains.
Colicchio R; Nigro E; Colavita I; Pagliuca C; Di Maro S; Tomassi S; Scaglione E; Carbone F; Carriero MV; Matarese G; Daniele A; Cosconati S; Pessi A; Salvatore F; Salvatore P
FASEB J; 2021 Dec; 35(12):e22026. PubMed ID: 34818435
[TBL] [Abstract][Full Text] [Related]
10. Synergistic effects of antimicrobial peptide DP7 combined with antibiotics against multidrug-resistant bacteria.
Wu X; Li Z; Li X; Tian Y; Fan Y; Yu C; Zhou B; Liu Y; Xiang R; Yang L
Drug Des Devel Ther; 2017; 11():939-946. PubMed ID: 28356719
[TBL] [Abstract][Full Text] [Related]
11. Multidrug-Resistant Enterococcal Infections: New Compounds, Novel Antimicrobial Therapies?
van Harten RM; Willems RJL; Martin NI; Hendrickx APA
Trends Microbiol; 2017 Jun; 25(6):467-479. PubMed ID: 28209400
[TBL] [Abstract][Full Text] [Related]
12. An ancient solution to a modern problem.
Davies JE; Behroozian S
Mol Microbiol; 2020 Mar; 113(3):546-549. PubMed ID: 32185831
[TBL] [Abstract][Full Text] [Related]
13. A review on antimicrobial botanicals, phytochemicals and natural resistance modifying agents from Apocynaceae family: Possible therapeutic approaches against multidrug resistance in pathogenic microorganisms.
Anand U; Nandy S; Mundhra A; Das N; Pandey DK; Dey A
Drug Resist Updat; 2020 Jul; 51():100695. PubMed ID: 32442892
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial Peptide Exposure Selects for Resistant and Fit Stenotrophomonas maltophilia Mutants That Show Cross-Resistance to Antibiotics.
Blanco P; Hjort K; Martínez JL; Andersson DI
mSphere; 2020 Sep; 5(5):. PubMed ID: 32999081
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial activities and membrane-active mechanism of CPF-C1 against multidrug-resistant bacteria, a novel antimicrobial peptide derived from skin secretions of the tetraploid frog Xenopus clivii.
Xie J; Gou Y; Zhao Q; Wang K; Yang X; Yan J; Zhang W; Zhang B; Ma C; Wang R
J Pept Sci; 2014 Nov; 20(11):876-84. PubMed ID: 25098547
[TBL] [Abstract][Full Text] [Related]
16. Combining topology and sequence design for the discovery of potent antimicrobial peptide dendrimers against multidrug-resistant Pseudomonas aeruginosa.
Stach M; Siriwardena TN; Köhler T; van Delden C; Darbre T; Reymond JL
Angew Chem Int Ed Engl; 2014 Nov; 53(47):12827-31. PubMed ID: 25346278
[TBL] [Abstract][Full Text] [Related]
17. Novel antimicrobial agents against multi-drug-resistant gram-negative bacteria: an overview.
Karras G; Giannakaki V; Kotsis V; Miyakis S
Recent Pat Antiinfect Drug Discov; 2012 Dec; 7(3):175-81. PubMed ID: 23061790
[TBL] [Abstract][Full Text] [Related]
18. Fighting back: peptidomimetics as a new weapon in the battle against antibiotic resistance.
Bragonzi A
Sci Transl Med; 2010 Mar; 2(21):21ps9. PubMed ID: 20374995
[TBL] [Abstract][Full Text] [Related]
19. Motuporamine Derivatives as Antimicrobial Agents and Antibiotic Enhancers against Resistant Gram-Negative Bacteria.
Borselli D; Blanchet M; Bolla JM; Muth A; Skruber K; Phanstiel O; Brunel JM
Chembiochem; 2017 Feb; 18(3):276-283. PubMed ID: 28098416
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial Face Shield: Next Generation of Facial Protective Equipment against SARS-CoV-2 and Multidrug-Resistant Bacteria.
Tuñón-Molina A; Martí M; Muramoto Y; Noda T; Takayama K; Serrano-Aroca Á
Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
